Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 53 Breast Neoplasms 26 Lung Neoplasms 21 Triple Negative Breast Neoplasms 16 Neoplasm Metastasis 16 Pancreatic Neoplasms 15 Neoplasms 15 Stomach Neoplasms 14 Colorectal Neoplasms 14 Head and Neck Neoplasms 12 Esophageal Neoplasms 12 Esophageal Squamous Cell Carcinoma 11 Uterine Cervical Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Small Cell Lung Carcinoma 10 Rectal Neoplasms 9 Ovarian Neoplasms 8 Leukemia, Myeloid, Acute 8 Recurrence 7 Nasopharyngeal Carcinoma 7 Glioblastoma 5 Fallopian Tube Neoplasms 5 Cholangiocarcinoma 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Oropharyngeal Neoplasms 4 Mouth Neoplasms 4 Lymphoma 4 Endometrial Neoplasms 4 Colonic Neoplasms 4

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Drug Therapy × 1 year × Clear all

NCT06731140 2025-11-17

Resilire

Fudan University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡